Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
TargetGene Biotechnologies
Rishon LeZion, Israel
B
1-10 Employees
2012
Key takeaway
TargetGene has developed a leading genome editing platform and is now prepared to collaborate in the therapeutics sector, highlighting its commitment to advancing cures through innovative gene editing technologies.
Reference
Core business
TARGETGENE – DEVELOPING THE WORLD’S BEST THERAPEUTIC GENOME EDITING PLATFORM
Geneyx
Herzliya, Israel
B
11-50 Employees
2018
Key takeaway
Geneyx is focused on integrating comprehensive genomic insights into healthcare and pharmaceutical research, enhancing their platform with AI/ML tools for efficient analysis of germline and somatic sequencing data. Their CE-IVD-certified Geneyx Analysis platform supports various stages of the bioinformatics pipeline, promoting automation and customizable reporting, which significantly accelerates genetic diagnosis and research.
Reference
Core business
NGS Data Analysis | Clinical Genome Research | Geneyx
Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders Geneyx
QR Genetics
Tel-Aviv, Israel
B
1-10 Employees
2019
Key takeaway
QRGenetics is focused on developing a drug-discovery engine that utilizes AI and exclusive analytics to identify novel drug targets for genetic diseases, which may have implications for gene editing and precision medicine.
Reference
Core business
A drug development engine for genetic diseases A drug development engine for genetic diseases
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
NewStem
Jerusalem, Israel
B
1-10 Employees
2016
Key takeaway
NewStem is a Bio-Platform company that develops precision medicine therapeutics for cancer, utilizing innovative haploid human embryonic stem cell (HhESC) technology. Their focus on synthetic lethal interactions with cancer-related mutations positions them at the forefront of advanced cancer research and diagnostics.
Reference
Core business
NewStem | Haploid HESC: Half the Genome - Infinite Potential
Our proprietary haploid human embryonic stem cell technology changes the paradigm to develop diagnostic (i.e., cancer), therapeutic & reproductive treatments.
Tarom Applied Technologies
Drom HaSharon Regional Council, Israel
B
11-50 Employees
1989
Key takeaway
The company, Tarom, introduces advanced technologies and products tailored to meet customer needs, highlighting their expertise in areas such as molecular diagnostics through their partnership with GenDx, which specializes in HLA typing and sequencing-based technologies. Additionally, Celsee Diagnostics offers innovative products in the liquid biopsy field, focusing on the detection of circulating tumor cells and single-cell biomarker analysis.
Reference
Product
GenDx - Tarom Applied technologies
GenDX develops and provides the tools for HLA typing, including reagents and analysis software. GenDx is a pioneer in Sequencing-Based Typing, providing platforms for both Sanger and Next Generation Sequencing
NRGene
Ness Ziona, Israel
B
11-50 Employees
2009
Key takeaway
NRGene utilizes advanced genomic data to optimize natural resources for sustainable agriculture and food security, which aligns with the principles of gene editing for enhancing crop traits and nutritional profiles. Their innovative approach and commitment to sustainability underscore their role in addressing global challenges through cutting-edge agricultural solutions.
Reference
Core business
NRGene – Growing the future. Together. Home - NRGene - Growing the future. Together.
Growing the future. Together. At NRGene - Growing the future. Together., we understand the urgency of finding solutions to make our planet sustainable for all life.
1E Therapeutics
Rishon LeZion, Israel
B
51-100 Employees
2020
Key takeaway
1E Therapeutics is pioneering the development of programmable oligonucleotide therapeutics that can precisely silence disease-causing RNAs, which may have implications for gene editing approaches in treating various diseases. Their innovative platform focuses on addressing challenging medical conditions through advanced RNA silencing techniques.
Reference
Core business
The future of therapeutic RNA silencing
EdiTy Therapeutics
Ness Ziona, Israel
B
1-10 Employees
2020
Key takeaway
Edity Therapeutics is pioneering a platform that leverages immune cells to deliver therapeutic proteins directly into the cytoplasm of diseased cells, enabling cellular reprogramming. This innovative approach targets various diseases, including genetic disorders and cancer, through mechanisms like protein replacement and genetic correction.
Reference
Core business
Home - Edity Therapeutics
Edity Therapeutics - Cellular Re-programming utilizing the Immune system: We use immune cells to deliver protein directly to the cytoplasm of diseased cells to improve patient health and longevity.
SBI Japan-Israel Innovation Fund
Herzliya, Israel
B
- Employees
2017
Key takeaway
LogicBio is focused on developing cures for serious, early-onset rare diseases by integrating advanced technologies in gene therapy and gene editing.
Reference
Core business
Home | SBIJI
CanBreed
Emek HaYarden Regional Council, Israel
B
1-10 Employees
2017
Key takeaway
CanBreed is a pioneer in applying CRISPR-Cas9 gene editing technology to develop stable and uniform Cannabis seeds, addressing the industry's challenges related to seed reliability and consistency. Their innovative approach enhances the cultivation process by introducing unique agronomical traits, ultimately benefiting both growers and consumers.
Reference
Core business
CanBreed
Perfecting Cannabis Genetics We perfect Cannabis and Hemp genetics for the benefit of the growers and the consumers
Technologies which have been searched by others and may be interesting for you:
When exploring the gene editing industry in Israel, several key considerations should be taken into account. Israel has a robust biotechnology ecosystem supported by strong academic research and government initiatives, providing a fertile ground for innovation. Regulatory frameworks are stringent, emphasizing ethical standards, especially concerning human genetic modifications. Companies must navigate these regulations while ensuring compliance with international norms, which can pose challenges but also enhance credibility. The competitive landscape in Israel is dynamic, with numerous startups and established firms focusing on CRISPR technology and other gene editing methods. Collaborations between academia and industry are common, fostering advancements and creating opportunities for investment. Environmental concerns are increasingly relevant, as gene editing has potential implications for biodiversity and ecosystem stability. Addressing these concerns can not only mitigate risks but also enhance public acceptance and marketability. The global market relevance of gene editing continues to grow, with applications in agriculture, medicine, and environmental management, positioning Israeli companies as key players in international markets. Understanding these factors is crucial for anyone interested in the gene editing sector in Israel, as they significantly influence the industry's trajectory and potential for innovation.
Some interesting numbers and facts about your company results for Gene Editing
| Country with most fitting companies | Israel |
| Amount of fitting manufacturers | 133 |
| Amount of suitable service providers | 58 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1989 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Gene Editing
What are related technologies to Gene Editing?
Based on our calculations related technologies to Gene Editing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Gene Editing?
The most represented industries which are working in Gene Editing are Biotechnology, Other, IT, Software and Services, Medical, Pharmaceuticals
How does ensun find these Gene Editing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.